|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.475 USD | +4.43% |
|
-8.27% | +82.12% |
| Apr. 16 | Allogene Therapeutics announces closing of $200.4 million public offering of common stock | RE |
| Apr. 16 | Top Midday Gainers | MT |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.43% | -8.27% | +9.91% | +58.92% | +82.12% | +72.07% | -48.45% | -92.29% | - | 785M | |
| +0.79% | +5.01% | +16.27% | +6.36% | -0.08% | +36.63% | +103.23% | +211.12% | +6,720.95% | 52.04B | |
| -1.10% | -0.50% | +15.98% | +1.30% | +16.57% | +101.80% | +23.15% | -5.84% | - | 46.83B | |
| +1.63% | -6.14% | +0.96% | -11.13% | -16.51% | +100.01% | +712.24% | +350.57% | +972.40% | 30.82B | |
| +2.21% | +9.38% | +10.11% | -1.05% | +9.72% | +5.77% | -16.27% | -30.12% | - | 25.82B | |
| -3.93% | +0.51% | +2.47% | -10.21% | +13.61% | +76.83% | -34.82% | -65.98% | - | 19.66B | |
| +1.03% | +0.87% | +5.40% | -11.63% | -10.93% | +39.10% | -37.85% | -18.08% | +89.85% | 17.31B | |
| +1.34% | +11.44% | +29.50% | +24.79% | +33.63% | +80.41% | +219.92% | +187.07% | - | 17.54B | |
| +2.07% | +26.23% | +56.66% | +54.61% | +41.97% | +0.89% | +1,451.88% | +382.14% | +248.74% | 18.93B | |
| -0.38% | +7.17% | +25.06% | +9.75% | +32.59% | +79.93% | - | - | - | 15.56B | |
| +0.99% | +2.61% | +20.31% | +5.59% | -8.44% | +76.75% | +107.83% | +339.96% | - | 12.04B | |
| +1.99% | +2.10% | +8.06% | +3.24% | +3.13% | +24.90% | +128.86% | +90.40% | +927.27% | 11.53B | |
| +1.61% | +11.33% | +32.34% | +22.60% | +66.53% | +243.55% | +132.82% | +27.01% | - | 11.07B | |
| +0.33% | +17.79% | +18.25% | -6.45% | -18.03% | - | - | - | - | 10.25B | |
| +3.19% | +8.20% | +22.42% | +7.97% | +6.16% | +527.05% | +124.89% | +5.19% | +996.11% | 9.52B | |
| -0.73% | +1.99% | +11.91% | +30.66% | +34.57% | +102.58% | +46.65% | +252.98% | - | 8.95B | |
| +1.91% | +2.88% | +6.80% | -0.22% | +5.08% | +47.54% | +247.13% | - | - | 8.17B | |
| +0.19% | +0.85% | +5.53% | +2.80% | +3.19% | +66.07% | +80.07% | +165.12% | +698.60% | 8.06B | |
| +5.17% | +4.33% | -7.49% | +17.21% | +283.59% | +207.49% | +243.67% | -55.22% | - | 7.49B | |
| +1.54% | +4.60% | +1.69% | +12.44% | +40.43% | +49.47% | +73.77% | +689.25% | +318.53% | 7.76B | |
| Average | +1.21% | +2.91% | +14.61% | +10.88% | +30.94% | +102.04% | +197.71% | +143.14% | +1,371.56% | 17.01B | |
| Weighted average by Cap. | +0.72% | +3.83% | +15.51% | +6.39% | +17.37% | +83.42% | +219.13% | +142.37% | +2,655.94% |
- Stock Market
- Equities
- ALLO Stock
- Sector Allogene Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
